Understand and manage immune responses in drug and vaccine development
As targeted immune therapies grow in complexity, understanding and controlling immune regulation has never been more important in the design of therapeutics.
Join experts in both academic and commercial immunology at Mastering Immunity 2019 for a focussed conference to learn the latest developments in this fast-developing field covering multiple aspects of in the development of modern therapeutics. This focussed meeting is a forum for key people involved in wanting to characterize immune modulation following delivery of biologics and other therapies to come together to share knowledge, perspectives and discuss solutions to the complex challenges of immunity in this context. We will focus on manipulation and characterization of both desired (in immuno-oncology and vaccines) as well as unwanted immune responses (i.e. immunogenicity to biotherapeutics or viral vectors).
This year’s meeting in Cambridge, MA, is now in its eighth consecutive year having also been held in Oxford, UK. It offers an unparalleled opportunity to meet are share information with like-minded scientists from other organisations, and to help shape the future of your R&D programs.
How will I benefit?
Feedback from previous conferences:
“Mastering Immunogenicity captured the breadth and depth of immunogenicity issues faced by industry today” (Tim Hickling, Pfizer)
“I absolutely enjoyed the talks and very much liked the small and highly interactive fomat of the meeting. The quality of the program was very high and I indeed picked up some useful ideas that I am incorporating into our programs.” (Shahla Abodollahi, Celgene)
“It has been a terrific opportunity to learn more about immunology, and immunogenicity in particular, from esteemed colleagues in the field, interacting with them and sharing some of my views on the topic. I look forward to more of these.” (Andrea Ferrante, Eli Lilly)
“I also had a great time during the meeting. It was truly excellent in content and organization.” (Julio Delgado, University of Utah)
“It was a terrific event, with excellent speakers and great networking/brainstorming opportunities at the breaks and with the roundtable” (Valerie Quarmby, Genentech)
“Great first experience. I enjoyed the breadth of topics” (Laurent Malherbe, Eli Lilly)
“Great speakers with diverse topics. I enjoyed the deep science and also the opinions from experts in the field” (Xiaoying Chen, Pfizer)
“Covered a diverse array of subjects. I enjoyed the networking opportunities” (Shinu John, Moderna Therapeutics)
“Excellent event” (George Gunn, Janssen R&D)
“Really liked the interactive environment. In-depth discussions with very relevant colleagues”
“I really enjoyed the very good quality, sparkling diversity, but still keeping focus”
“Very nice and comprehensive topics in this symposium. I have learnt a lot from it.” (Pu Shi, Takeda)
“This is a fantastic conference that is a good mix of vaccine and biotherapeutic folks. Facilitates learning and collaboration.” (Priya Sriraman, Celgene)
The city of Boston is an international center of higher education and a center for medicine and biotechnology, and consequently is a fitting location for ProImmune’s Mastering Immunity conference. The venue is the Museum of Science, one of the world’s largest science centers, and New England’s most highly attended cultural institution.
The meeting will take place in the Skyline Room on the Museum’s top floor, with panoramic views of the Charles River, Back Bay, Boston and Cambridge through two walls of floor-to-ceiling windows.
Delegates are responsible for arranging their own accommodation. The following are suggested options for accommodation in the vicinity of the conference venue:
Royal Sonesta Hotel
Kimpton Hotel Marlowe
Fairfield Inn & Suites by Marriott
Hampton Inn Boston Cambridge
For drivers: Delegates are offered free parking validation at the Museum Car Park
For rail users: the closest T stop is ‘Science Park’ on the Green Line (4 min walk); for the Red Line use ‘Kendall Square’ (20 min walk)
Telephone (toll free): USA & Canada +1 888 505 7765
All other countries +44 (0) 870 042 7279